Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.48 |
| ▸ | HPGD | P15428 | 7/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 5/20 | 0.48 |
| ▸ | GAA | P10253 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | IGLV6-57 | P01721 | 6/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3952916 | 0.94 | ALDH1A1 (0.44) | ALDH1A1KDM4EHPGDSMN1; SMN2NPC1 | |
| SCHEMBL3958792 | 0.76 | NDUFS8 (0.45) | ALDH1A1KDM4ECA12CA9MAOB | |
| SCHEMBL20581664 | 0.75 | FPR1 (0.39) | ALDH1A1KDM4EGLAGAAKMT2A | |
| SCHEMBL28382736 | 0.75 | FPR1 (0.39) | ALDH1A1KDM4EGLAGAAKMT2A | |
| SCHEMBL8602180 | 0.74 | LMNA (0.37) | LMNA | |
| Palmitic Acid SCHEMBL5886483 | 0.74 | ALDH1A1 (0.66) | ALDH1A1KDM4EHPGDSMN1; SMN2NPC1 | |
| SCHEMBL16406163 | 0.73 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDSMN1; SMN2NPC1 | |
| SCHEMBL9938570 | 0.72 | LMNA (0.49) | ALDH1A1SMN1; SMN2LMNAL3MBTL1 | |
| SCHEMBL12386901 | 0.72 | IGLV6-57 (0.60) | ALDH1A1KDM4EHPGDSMN1; SMN2NPC1 | |
| SCHEMBL31489975 | 0.71 | AKR1C3 (0.47) | ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090104711-A1 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | SIM HYUN-HO | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104711-A1 | FLUORESCENT MARKER COMPRISING DOUBLE BOND ESTER GROUP AND METHOD FOR MARKING AND DETECTING THE SAME | ELOVL1, FASN, ELOVL5 | ALDH1A1 270/4885KDM4E 4257/4885HPGD 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.